Solventum Corporation SOLV
84.46 USD -0.29 (-0.34%)
Nov 3, 2026, 3:51 PM EST
83.71 Day range 85.38
62.49 52-week range 92.44
- YTD
- +6.59%
- 1 year
- +23.99%
Analyst view
Consensus: buy
Buy
Price target (mean) 94.69 +12.1% upside
Now 84.46
- Target (low)
- 71.00
- Target (mean)
- 94.69
- Target (high)
- 113.00
Ratings (0m) 15 8 buy · 5 hold · 2 sell
- Strong buy1
- Buy7
- Hold5
- Sell1
- Strong sell1
Recommendation trend
- This month 15
- 1 month ago 15
- 2 months ago 15
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.34 | 1.29 – 1.39 | 1.50 | -10.4% | 1.93B | -7.8% | 11 |
| Next quarter | 1.79 | 1.74 – 1.90 | 1.57 | +14.2% | 2.09B | +4.5% | 11 |
| Current year | 7.18 | 7.11 – 7.55 | 6.11 | +17.5% | 8.23B | -1.2% | 15 |
| Next year | 7.27 | 6.46 – 7.60 | 7.18 | +1.2% | 8.52B | +3.6% | 15 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 14, 2026 | BTIG | Reiterated | Buy | Buy |
| Aug 6, 2026 | UBS | Maintained | Buy | Buy |
| Aug 6, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Aug 6, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Aug 6, 2026 | Keybanc | Maintained | Overweight | Overweight |
| Aug 6, 2026 | Stifel | Maintained | Buy | Buy |
| Aug 6, 2026 | BTIG | Maintained | Buy | Buy |
| Jul 28, 2026 | UBS | Upgrade | Neutral | Buy |
| Jul 9, 2026 | BMO Capital | Initiated | — | Market Perform |
| May 15, 2026 | Wedbush | Initiated | — | Outperform |
| May 6, 2026 | UBS | Maintained | Neutral | Neutral |
| May 6, 2026 | Stifel | Maintained | Buy | Buy |
| May 6, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| May 6, 2026 | Keybanc | Maintained | Overweight | Overweight |
| May 6, 2026 | BTIG | Reiterated | Buy | Buy |
| Apr 27, 2026 | Keybanc | Maintained | Overweight | Overweight |
| Apr 17, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Mar 24, 2026 | Rothschild & Co | Initiated | — | Sell |
| Feb 27, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Feb 27, 2026 | Keybanc | Maintained | Overweight | Overweight |
| Feb 27, 2026 | BTIG | Reiterated | Buy | Buy |
| Jan 26, 2026 | Keybanc | Upgrade | Sector Weight | Overweight |
| Jan 20, 2026 | Mizuho | Upgrade | Neutral | Outperform |
| Jan 7, 2026 | Stifel | Maintained | Buy | Buy |
| Dec 2, 2025 | BTIG | Upgrade | Neutral | Buy |
| Nov 10, 2025 | UBS | Maintained | Neutral | Neutral |
| Nov 7, 2025 | Piper Sandler | Maintained | Overweight | Overweight |
| Oct 1, 2025 | UBS | Initiated | — | Neutral |
| Sep 15, 2025 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Sep 11, 2025 | Jefferies | Initiated | — | Hold |